Hans-ulrich P. Hockey - Publications

Hospital Cost Savings for Sequential COPD Patients Receiving Domiciliary Nasal High Flow Therapy.

Journal: International journal of chronic obstructive pulmonary disease

Published: December 07, 2021

Development in PaCO2 over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula-post-hoc analysis from a randomised controlled trial.

Journal: BMJ open respiratory research

Published: August 06, 2020

Assessment of dispersion of airborne particles of oral/nasal fluid by high flow nasal cannula therapy.

Journal: PloS one

Published: May 27, 2020

Intravenous immunoglobulin significantly reduces exposure of concomitantly administered anti-C5 monoclonal antibody tesidolumab.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: November 08, 2019

Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study.

Journal: The Lancet. Rheumatology

Published: September 13, 2019

Comparison of pharmacokinetics, safety and tolerability of secukinumab administered subcutaneously using different delivery systems in healthy volunteers and in psoriasis patients.

Journal: British journal of clinical pharmacology

Published: June 19, 2019

Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure.

Journal: International journal of chronic obstructive pulmonary disease

Published: May 02, 2018

TORC1 inhibition enhances immune function and reduces infections in the elderly.

Journal: Science translational medicine

Published: October 07, 2017

Dry Eye Signs and Symptoms Persist During Systemic Neutralization of IL-1β by Canakinumab or IL-17A by Secukinumab.

Journal: Cornea

Published: September 30, 2015

A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: November 06, 2014

Phase 3 trial of domiciliary humidification to mitigate acute mucosal toxicity during radiation therapy for head-and-neck cancer: first report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM study.

Journal: International journal of radiation oncology, biology, physics

Published: October 02, 2013

Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures.

Journal: Anaesthesia and intensive care

Published: December 15, 2011